Since we did not individually test the functions of BTRC and determine the expression levels of hsa-miR-10a-5p and BTRC in specimens from osteosarcoma patients, it is difficult to conclude whether the expression levels of both molecules can be consistent between in vitro cell assays and clinical specimens. The gene discussed is BTRC; the disease is osteosarcoma.